Home Parenteral Nutrition in Cancer Patients

An Evaluation of Quality of Life Outcomes in Cancer Patients Receiving Home Parenteral

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01152879

Enrollment

100

Registered

2010-06-29

Start date

2010-05-31

Completion date

2013-06-30

Last updated

2014-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Parenteral Nutrition, Quality of Life

Brief summary

This study is being done to examine the effect of Parenteral (intravenous) nutrition support in the home setting on quality of life in cancer patients. In addition, this study is being done to examine the effect of home parenteral nutrition on the use of pain and anti-nausea medication.

Detailed description

This is a prospective descriptive non-randomized clinical study to examine quality of life outcomes and use of pain and anti-emetic therapy for patients receiving HPN support. The EORTC QLQ-C30 will be used to evaluate quality of life. All subjects will be monitored monthly throughout the course of treatment for a minimum of 3 months and a maximum of 1 year.

Interventions

DIETARY_SUPPLEMENTHome Parenteral Nutrition

Cancer Patients who are discharged on HPN will be monitored for quality of life, nutrition status, pain and nausea medication usage

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with a cancer diagnosis who have been receiving parenteral nutrition in the hospital or have started on HPN while at Cancer Treatment Centers of America and meet the criteria for home parenteral nutrition. * Patient expected to have a life expectancy of greater than 90 days post discharge.

Exclusion criteria

* Patients less than 18 years of age * HPN patients who do not receive nutrition assessment and follow-up by the Coram Healthcare nutrition support team * Refuse to participate

Design outcomes

Primary

Measure	Time frame	Description
Quality of Life	Monthly for a minimum of 3 months to a maximum of 12 months	To examine the effect of parenteral nutrition support in the home care setting on quality of life as measured by the EORTC QLQ-C30

Secondary

Measure	Time frame	Description
Pain and nausea medication usage	Monthly for a minumum of 3 months to a maximum of 12 months	To examine the effect of home parenteral nutrition on the use of pain medication and anti-emetic therapy administered intravenously, subcutaneously, or orally.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026